VaccinesNews.net

Vaccines Xagena

Search results for "Guillain-Barre syndrome"

Adverse neurologic reactions from smallpox vaccination were generally mild and the rate of specific syndromes did not exceed baseline estimates. Rare adverse events causally associated with smallp ...


Approximately 2.5 million people received the intranasal influenza vaccine the last 2 flu seasons, and a new study did not identify unexpected serious risks associated with use of this vaccine. Unt ...


On June 8th 2006, the FDA ( Food and Drug Administration ) announced the approval of Gardasil, and on June 29th the Advisory Committee on Immunizations Practices ( ACIP ) voted to recommend adding Gar ...


In a commentary published in the Canadian Medical Association Journal ( CMAJ ), Abby Lippman, an epidemiologist at McGill University in Montreal, Canada, and colleagues wrote that there is no urgent n ...


The FDA ( Food and Drug Administration ) has expanded the approved age range for Menactra, a bacterial meningitis vaccine, to include children ages 2 to 10 years. Meningitis is a serious inflammati ...


The National Vaccine Information Center ( NVIC ) issued a new report on HPV vaccine ( Gardasil ) safety analyzing adverse event reports to the federal Vaccine Adverse Event Reporting System ( VAERS ). ...


The influenza A(H1N1) 2009 monovalent vaccination programme was the largest mass vaccination initiative in recent US history. Commensurate with the size and scope of the vaccination programme, a proje ...


The possible risk of Guillain-Barré syndrome from influenza vaccines remains a potential obstacle to achieving high vaccination coverage. However, influenza infection might also be associated with Gui ...